|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with
Advanced Gastric Cancer
Jin Won Kim, Jong Gwang Kim, Byung Woog Kang, Ik-Joo Chung, Young Seon Hong, Tae-You Kim, Hong Suk Song, Kyung Hee Lee, Dae Young Zang, Yoon Ho Ko, Eun-Kee Song, Jin Ho Baek, Dong‐Hoe Koo, So Yeon Oh, Hana Cho, Keun-Wook Lee
Cancer Res Treat.
2019;51(1):223-239. Published online October 19, 2018 DOI:
https://doi.org/10.4143/crt.2018.073
Web of Science 12
Crossref 11
Wernicke's Encephalopathy in
Advanced Gastric Cancer
Eun Suk Jung, Obin Kwon, Soo Hyun Lee, Ki Byung Lee, Joo Hoon Kim, Sang Hyun Yoon, Gun Min Kim, Hei-Cheul Jeung, Sun Young Rha
Cancer Res Treat.
2010;42(2):77-81. Published online June 30, 2010 DOI:
https://doi.org/10.4143/crt.2010.42.2.77
Crossref 13
Prognosis of pN3 Stage Gastric Cancer
Jung Ryun Ahn, Minkyu Jung, Chan Kim, Min Hee Hong, Hong Jae Chon, Hye Ryun Kim, Hei-Cheul Jeung, Woo Jin Hyung, Sung Sook Lee, Hyun Cheol Chung, Sung Hoon Noh, Sun Young Rha
Cancer Res Treat.
2009;41(2):73-79. Published online June 30, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.2.73
Crossref 16
Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with
Advanced Gastric Cancer
Kyung Hee Lee, Myung Soo Hyun, Hoon-Kyo Kim, Hyung Min Jin, Jinmo Yang, Hong Suk Song, Young Rok Do, Hun Mo Ryoo, Joo Seop Chung, Dae Young Zang, Ho-Yeong Lim, Jong Youl Jin, Chang Yeol Yim, Hee Sook Park, Jun Suk Kim, Chang Hak Sohn, Soon Nam Lee
Cancer Res Treat.
2009;41(1):12-18. Published online March 31, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.1.12
Crossref 22
A Phase II Study of Paclitaxel and Cisplatin as Salvage Therapy for Patients with Advanced or Metastatic Gastric Cancer
Bong-Gun Seo, Sung Yong Oh, Dong Mee Lee, Hyun Seung Yoo, Suee Lee, Seong-Geun Kim, Sung-Hyun Kim, Hyuk-Chan Kwon, Hyo-Jin Kim
Cancer Res Treat.
2007;39(1):6-9. Published online March 31, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.1.6
Crossref 2
Cispatin , Etoposide , Leucovorin and 5-Fluorouracil ( PELF ) Combination Chemotherapy for
Advanced Gastric cancer
: Interim Report
Il Rang Park, Si Young Kim, Jeong Hee Kim, Hwi Joong Yoon, Kyung Sam Cho
J Korean Cancer Assoc.
1998;30(5):907-913.
Selection of Surgical Procedure in the Elderly with
Advanced Gastric Cancer
Hyeoung Joon Kim, Tae Kyung Sohn, Woo Joong Kim, Kyung Suk Chung
J Korean Cancer Assoc.
1998;30(5):892-899.
Results of Hyperthermic Treatment Combiced with Radiotherapy/Chemotherapy in Locally Advanced Inoperable Gastric Cancer
Chang Woo Moon, Ha Yong Yeom, Tae Sik Jung, Young Ho Kim, Ja Young Koo
J Korean Cancer Assoc.
1998;30(4):639-651.
5-Fluorouracil and Cisplatin ( FP ) Combination Chemotherapy in
Advanced Gastric Cancer
Keum Jung Kim, Jeong Hee Kim, Si Young Kim, Hwi Joong Yoon, Kyung Sam Cho
J Korean Cancer Assoc.
1995;27(3):383-389.
A Retrospective Comparison of Infusional 5-Fluorouracil , Doxorubicin , Mitomycin - C ( Modified FAM ) Combination Chemotherapy Versus Palliative Therapy in
Joon Oh Park, Jae Kyung Roh, Hyun Cheol Chung, Hyun Jin Noh, Jae Yong Cho, Sun Young Rha, Chong In Lee, Cheol Woo Kim, Joo Hang Kim, Choong Bai Kim, Sung Hoon Noh, Kyong Sik Lee, Jin Sik Min, Byung S
J Korean Cancer Assoc.
1995;27(2):165-175.
A Phase 2 Study on Combined 5 - Fluorouracil , Etoposide , Doxorubicin and Cisplatin ( F - EAP ) in Patients with
Advanced Gastric Cancer
J Korean Cancer Assoc.
1994;26(1):9-16.
1
Journal Impact Factor 4.6